Insulin Resistance – Comprehensive Knowledge

Insulin constitutes a pivotal peptide hormone synthesized by the β-cells (beta cells) of the pancreatic islets of Langerhans, whose secretion is triggered in response to postprandial elevations in blood glucose concentrations. Its primary physiological function involves facilitating the transmembrane transport of glucose into target cells—most notably skeletal myocytes, hepatocytes, and adipocytes—through binding to specific membrane-bound receptors and initiating the PI3K/Akt signaling cascade. Beyond this, insulin orchestrates anabolic processes, including muscular glycogen synthesis (the storage of glucose as glycogen), enhances the uptake of essential amino acids for muscle protein synthesis (via activation of the mTORC1 pathway), and modulates lipid metabolism by suppressing lipolysis while promoting lipogenesis in adipose tissue (Brzozowski, 2019). Conversely, insulin resistance (IR) denotes a pathological condition characterized by diminished responsiveness of peripheral tissues to insulin action despite maintained fasting euglycemia, leading to compensatory hyperinsulinemia. The progression of this dysfunction culminates in impaired glucose tolerance and, ultimately, chronic hyperglycemia, which serves as the primary risk factor for the development of type 2 diabetes mellitus. Furthermore, IR is closely associated with metabolic syndrome (abdominal obesity, dyslipidemia with hypertriglyceridemia, arterial hypertension) and exhibits links to the pathogenesis of affective disorders, including major depressive episodes (Mamcarz et al., 2015; Watson et al., 2021).

The likelihood of insulin resistance emergence is shaped by a combination of hereditary predispositions and lifestyle-related as well as environmental influences. Individuals whose immediate family members—specifically parents or siblings—have been diagnosed with this condition are classified within a high-risk category. Ethnic background also emerges as a significant determinant, with markedly elevated prevalence rates observed among African American populations, Alaska Native communities, Native American tribes, individuals of Asian descent, Hispanic or Latino populations, Native Hawaiians, and Pacific Islander groups. Nevertheless, a gradual upward trend in incidence has likewise been documented across European populations. Furthermore, an individual’s health status plays a pivotal role: those with a medical history of metabolic syndrome, hypertension, cardiovascular diseases, polycystic ovary syndrome (PCOS), Cushing’s syndrome, or gestational diabetes exhibit a substantially heightened susceptibility to developing insulin resistance compared to their counterparts without such preexisting conditions.

During the initial stages of insulin resistance development, the majority of individuals exhibit no discernible symptoms; however, a subset of patients may present with subtle yet bothersome systemic manifestations. These primarily include persistent fatigue and excessive drowsiness—particularly pronounced following the consumption of carbohydrate-rich meals. Additionally, affected individuals frequently report difficulties in sustaining prolonged attention spans, episodic mood fluctuations with depressive undertones, and sudden bouts of intense hunger colloquially referred to as "ravenous appetite." Compounding these issues are thermoregulatory disturbances marked by excessive perspiration, as well as challenges in weight management despite adherence to a balanced dietary regimen. In the disease’s later phases, distinctive dermatological alterations may emerge, such as hyperpigmented, velvety skin patches (known clinically as *acanthosis nigricans*) or localized epidermal hyperkeratosis in specific body regions.

A definitive diagnosis of insulin resistance can only be established by a qualified healthcare provider based on ordered laboratory tests and their expert interpretation. The **most precise yet clinically underutilized method** is the **hyperinsulinemic-euglycemic clamp technique**—an invasive 120-minute procedure involving continuous intravenous insulin infusion while measuring the glucose required to maintain steady glycemia. Due to its high cost and complexity, this approach is primarily reserved for research rather than routine diagnostics (Paschos & FitzGerald, 2013). In outpatient settings, the **standard diagnostic protocol** involves assessing **fasting glucose and insulin levels**, followed by calculation of the **HOMA-IR index** (*Homeostatic Model Assessment of Insulin Resistance*). A reference value of 1.0 is considered normal, whereas values ≥2.0 indicate insulin resistance. Elevated fasting insulin (>10 mU/ml) may also suggest metabolic dysfunction (Paschos & FitzGerald, 2013). When HOMA-IR results are equivocal, an **oral glucose tolerance test (OGTT)**, colloquially termed the "glucose curve," is recommended. This involves administering 75 g of glucose after fasting, with glycemic measurements taken at baseline, 60 minutes, and 120 minutes post-ingestion. A normal 2-hour result should not exceed 140 mg% (7.8 mmol/l) (Park et al., 2021).

While the most widely recognized consequence of insulin resistance remains the onset of type 2 diabetes, this metabolic dysfunction also serves as a critical risk factor for a broad spectrum of additional hormonal and systemic disorders. Among the most prevalent complications is metabolic syndrome—a multifaceted physiological dysfunction characterized by excessive visceral adiposity, persistent arterial hypertension, and impaired glucose tolerance. Furthermore, prolonged disregard for insulin resistance substantially elevates the likelihood of developing polycystic ovary syndrome (PCOS) in women, accelerates the progression of atherosclerosis and cardiovascular diseases, and fosters the emergence of non-alcoholic fatty liver disease (NAFLD), which may advance to cirrhosis or even primary liver carcinoma.

The best way to treat insulin resistance is to have a healthy and balanced diet based on the right dietary approach (Y. T. Wondmkun 2020). A very important aspect to be aware of is the fact that every person's weight loss disorder is very often coupled with excess body fat, so it's worth introducing an energy deficit. Its size depends on the baseline weight of kilograms and should be picked individually. The effect can be to improve tissue insulin sensitivity (Y.. T.Wondmkün 2020). Any diet that is based on a balanced and healthy diet is very important to keep in mind, because it also has a higher fat content and a higher body fat content.

Structured physical activity represents a cornerstone in the effective management of insulin resistance, exerting multifaceted beneficial effects on metabolic regulation. Primarily, it facilitates the maintenance of a healthy body weight or gradual reduction of excess adiposity by elevating daily energy expenditure, thereby promoting a balanced energy equation. More critically, consistent exercise substantially enhances the insulin sensitivity of skeletal muscle, adipose tissue, and hepatic cells—this improvement stems from the fact that contracting muscles exhibit an augmented capacity for glucose uptake from circulation, which consequently alleviates pancreatic demand for insulin secretion. Furthermore, empirical evidence demonstrates that physical activity activates complementary glucose metabolic pathways (e.g., via AMP-activated protein kinase stimulation) while concurrently attenuating low-grade chronic inflammation, a condition frequently associated with insulin resistance and its downstream complications (Warburton & Bredin, 2017). It is essential to recognize that even moderate-intensity movement yields measurable benefits, provided it is performed with regularity. The adoption of sustainable habits proceeds most effectively when selected activities align with personal preferences—whether dancing, swimming, cycling, or brisk walking. Although the most robust outcomes are observed when resistance training (e.g., bodyweight exercises or weightlifting) is combined with endurance-based activities (such as jogging, cycling, or aerobic routines), a mere 30-minute brisk walk confers significantly greater metabolic advantages than a sedentary lifestyle (Mann et al., 2014).

Implementing modifications to daily routines can significantly enhance the body’s responsiveness to insulin. Research has demonstrated that abstaining from stimulants such as cigarettes contributes to glucose level stabilization and a reduction in inflammatory states. Furthermore, maintaining proper sleep hygiene and stress management play pivotal roles in regulating metabolic processes, including the secretion of hormones that govern appetite and carbohydrate metabolism. Additionally, limiting alcohol consumption may prevent disruptions in glucose metabolism and protect the liver from damage that could exacerbate insulin resistance.

Insulin resistance represents a multifaceted metabolic derangement characterized by diminished peripheral tissue responsiveness to insulin, thereby compromising glycemic regulation. Genetic predispositions, ethnic background, particularly visceral obesity, sedentary behavior, chronic oxidative and psychological stress, diets rich in ultra-processed high-calorie foods, persistent sleep deprivation, and excessive alcohol consumption are well-documented contributors to the development of this condition. In its initial phases, insulin resistance may remain clinically silent or present with nonspecific symptomatology, including persistent fatigue, cognitive impairments such as difficulty concentrating, episodes of excessive sweating unrelated to physical exertion, depressed mood states, and an inclination toward weight gain despite conventional weight-loss efforts. Left untreated, this metabolic dysfunction may progress to overt type 2 diabetes mellitus and significantly elevate susceptibility to cardiovascular diseases — including atherosclerosis and hypertension — polycystic ovary syndrome in women, non-alcoholic fatty liver disease, and other insulin-mediated metabolic disorders. Core therapeutic recommendations emphasize the adoption of personalized low-glycemic-index dietary regimens, the gradual incorporation of moderate physical activity tailored to individual capabilities, and — in cases of overweight or obesity — structured weight reduction under professional supervision. Effective implementation of these lifestyle modifications has been shown to enhance insulin receptor sensitivity, normalize blood glucose profiles, and mitigate the long-term risk of complications associated with insulin resistance.